Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5525_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Acknowledgments
- •Editor biographies
- •Yi Wang
- •X. Sharon Qi
- •List of contributors
- •1.2.3 Feature engineering and representation
- •1.2.4 Linear separability
- •1.2.5 Classical models
- •1.1 A brief introduction to AI
- •1.2 Machine learning basics
- •1.2.1 Learning paradigms
- •1.3 Artificial neural networks
- •1.3.1 Feed-forward neural networks
- •1.3.2 Recurrent neural networks
- •1.3.3 Convolutional neural networks
- •1.3.4 Attention
- •1.3.5 Training neural networks
- •1.3.6 Applications and use cases of deep learning
- •1.4 Model training and evaluation
- •1.4.1 Hyperparameters
- •1.4.2 Data split
- •1.4.3 Evaluation metrics
- •1.5 Generative models
- •1.5.1 Generative adversarial networks
- •1.5.2 Diffusion models
- •1.5.3 Applications and use cases
- •1.6 Ethical consideration and bias
- •1.6.1 Transparency and explainability
- •1.6.2 Bias and fairness
- •1.6.3 Data privacy violation
- •1.6.4 Risk and misuse
- •1.7 Summary
- •References
- •2.1 Introduction
- •2.1.2 Staff roles in radiation therapy
- •2.2 Overview of AI in radiation therapy
- •2.2.1 Patient evaluation and dose prescription
- •2.2.2 Treatment simulation
- •2.2.3 Contouring
- •2.2.4 Treatment planning
- •2.2.5 Quality assurance
- •2.2.6 Treatment delivery
- •2.2.7 Response assessment and toxicity management
- •2.3 Summary
- •3.1 Introduction
- •3.1.1 Introduction of clinical decision making and AI
- •3.1.2 The role of AI in clinical decision making
- •3.2 AI algorithms for clinical decision making
- •3.2.2 Radiomics
- •3.2.3 Data integration by AI
- •3.2.4 Interpretability of AI models
- •3.3 Application of AI in clinical decision making
- •3.3.1 Diagnosis and disease phenotyping
- •3.3.2 Personalized treatment
- •3.3.3 Treatment outcome and prognosis prediction
- •3.4 Challenges and future directions of AI in clinical decision making
- •3.4.1 Challenges and concerns
- •3.4.2 Future directions
- •3.5 Summary
- •References
- •4.1 Introduction
- •4.2 Imaging for treatment planning
- •4.2.1 CT simulation
- •4.2.2 4D-CT
- •4.2.3 PET/CT
- •4.2.4 MRI
- •4.3 Imaging for treatment guidance
- •4.3.1 Portal imaging
- •4.3.2 CBCT
- •4.3.3 CT-on-rail and CT-linac
- •4.3.4 MR-linac
- •4.3.5 PET-linac
- •4.4 Imaging for motion management
- •4.4.1 ExacTrac
- •4.4.2 Varian triggered imaging
- •4.4.3 4D-CBCT
- •4.4.4 Cine MRI
- •4.4.5 4D-MRI
- •4.4.6 Surface imaging
- •4.5 Imaging for treatment assessment
- •4.5.1 Contrasted CT
- •4.5.2 PET/CT
- •4.5.3 Functional MRI
- •4.6 Summary
- •5.1 Introduction to big data in radiation oncology
- •5.1.1 Overview of big data
- •5.1.2 Sources of big data in radiation oncology
- •5.1.3 Big data and AI in radiation oncology
- •5.2 Big data lifecycle in radiation oncology
- •5.2.1 Data aggregation and storage
- •5.2.2 Data sharing and security
- •5.4 The application of big data in radiation oncology
- •5.4.1 Medical image segmentation
- •5.4.2 Automatic treatment planning
- •5.4.3 Treatment response prediction
- •5.4.4 Quality assurance and patient safety
- •5.4.5 Clinical decision support
- •5.2.3 Data visualization
- •5.2.4 Knowledge creation and implementation
- •5.2.5 Data archiving and deletion
- •5.3 Big data analytics with AI
- •5.3.1 Data processing and integration
- •5.3.2 AI modeling
- •5.5 Challenges and future perspectives
- •5.6 Summary
- •Reference
- •6.1 The road to ART
- •6.1.1 3D conformal radiotherapy (3DCRT)
- •6.1.2 Intensity modulated radiotherapy (IMRT)
- •6.1.3 Image-guided radiotherapy (IGRT)
- •6.1.4 Adaptive radiotherapy (ART)
- •6.2 ART workflow and implementation
- •6.2.2 Current practice
- •6.2.3 Clinical impact
- •6.3 Considerations for implementing online ART
- •6.3.1 Time as a limiting factor
- •6.3.2 Implications for fast and reliable re-planning
- •6.3.4 Clinical considerations
- •6.4 Summary
- •7.1 Components of ART workflow
- •7.1.1 Simulation
- •7.1.2 Pre-planning
- •7.1.3 Online imaging and daily re-planning
- •7.1.4 Quality assurance
- •7.2 AI-driven ART
- •7.2.1 Simulation
- •7.2.2 Pre-planning
- •7.2.3 AI for delivery
- •7.3 Outlook and future directions
- •7.3.1 Real-time ART with AI
- •7.3.2 Dose escalation and functional adaption with AI
- •7.4 Summary
- •References
- •8.1 Introduction
- •8.2 Synthetic CT: deep learning methods
- •8.2.1 Conventional methods
- •8.2.2 U-Net
- •8.2.3 Generative adversarial networks
- •8.2.4 Denoising diffusion probabilistic model
- •8.3 Synthetic CT from CBCT
- •8.3.1 Noise and artifact reduction
- •8.3.2 Online dose calculation
- •8.3.3 Online image segmentation
- •8.4 Synthetic CT from MRI
- •8.4.1 Synthetic image accuracy
- •8.4.2 Dose calculation in MR-only radiation therapy
- •8.4.3 PET attenuation correction
- •8.4.4 Image registration
- •8.5 Discussion and outlook
- •8.6 Summary
- •References
- •9.1 AI-based image registration and segmentation for ART
- •9.1.1 Adaptive radiation therapy
- •9.2 Artificial intelligence
- •9.2.1 What is machine learning?
- •9.2.2 What is deep learning?
- •9.3 Deep learning: the basic components
- •9.3.1 Convolutional neural networks: looking at the picture
- •9.3.2 Pooling layers: keeping what matters most
- •9.3.3 Fully connected (dense) layers: bringing it all together
- •9.3.4 Activations
- •9.3.5 Loss: driving the model
- •9.3.6 Auto-encoders: remove the noise
- •9.3.7 Supervised versus unsupervised learning
- •9.3.8 Pre-trained convolutional neural networks
- •9.4 Image registration: bringing two images together
- •9.4.1 Registration similarity metrics
- •9.4.2 Types of registrations
- •9.5 AI-based image registration
- •9.5.1 Supervised learning
- •9.5.2 Unsupervised learning
- •9.5.3 Registration in ART
- •9.5.4 Commonalities in architectures
- •9.6 Image segmentation
- •9.6.1 Introduction: coloring by the numbers
- •9.6.2 Segmentation networks
- •9.6.3 Best practices
- •9.7 Summary
- •10.1 Introduction
- •10.1.1 Overview of chapter content
- •10.2 The landscape of AI-assisted dose prediction
- •10.2.1 Traditional machine learning for dose prediction
- •10.2.2 Deep learning-based dose prediction
- •10.2.3 Challenges in AI-assisted dose prediction
- •10.3 Re-planning workflows powered by AI
- •10.3.1 Deep learning for re-planning pipelines
- •10.4 Future directions of AI-assisted dose prediction and re-planning
- •10.5 Summary
- •11.1 Introduction
- •11.2.1 Imaging-based motion monitoring
- •11.2.2 Delivery system actions
- •11.2.3 Challenges for real-time ART implementation
- •11.3 AI in real-time ART workflows
- •11.3.1 Improving intrafraction motion monitoring through AI
- •11.3.2 Mitigating system latency through AI
- •11.4 AI for ART delivery: future directions
- •11.4.1 Management of non-respiratory motion
- •11.4.2 Training AI models with small or unpaired datasets
- •11.4.4 Biology-guided ART delivery
- •11.5 Summary
- •References
- •12.1 Introduction
- •12.2 Patient QA
- •12.2.1 Pre-planning QA
- •12.2.2 Pre-treatment plan QA
- •12.2.3 On-treatment QA
- •12.3 Treatment delivery systems and instruments
- •12.3.1 Machine commissioning
- •12.3.2 Machine QA
- •12.3.3 Dosimetry tool QA
- •12.4 Summary
- •References
- •13.1 Data resources for response modeling in radiotherapy
- •13.1.1 Clinical data
- •13.1.2 Imaging (radiomics)
- •13.1.3 Treatment planning (dosiomics)
- •13.1.4 Multiomics
- •13.2 Radiotherapy treatment outcome modeling
- •13.2.1 TCP/NTCP in radiotherapy
- •13.2.2 Clinical outcomes versus PROs
- •13.2.3 Machine learning response prediction
- •13.2.4 Explainability of ML response models
- •13.2.5 Sample use cases
- •13.3 AI response-based adaptive radiotherapy
- •13.3.1 Requirements and challenges
- •13.3.2 Prediction versus treatment optimization
- •13.3.3 Sample use cases
- •13.4 Challenges and recommendations
- •13.5 Summary
- •Acknowledgments
- •References
- •14.1 Overview of challenges in AI-driven ART
- •14.2 Data challenges
- •14.2.1 Data availability
- •14.2.2 Data quality
- •14.2.3 Data privacy
- •14.3 Technical challenges
- •14.3.2 Model robustness and generalizability
- •14.3.3 Model explainability and interpretability
- •14.4 Challenges associated with online and real-time workflows
- •14.4.1 Image quality
- •14.4.2 Dose calculation
- •14.4.3 Real-time ART
- •14.5 Operational challenges
- •14.5.1 Clinical validation
- •14.5.3 Staff training
- •14.5.4 User experiences
- •14.5.5 Quality management program
- •14.5.6 Financial challenges
- •14.6 Ethical, regulatory, and legal challenges
- •14.6.1 Ethical issues
- •14.6.2 Regulatory and legal issues
- •14.7 Summary
- •References
- •15.1 Clinical considerations for CT-based offline ART
- •15.1.1 Patient and site selection
- •15.1.2 Re-simulation
- •15.1.3 Re-planning
- •15.1.4 Plan summation and evaluation
- •15.1.6 Limitations and future directions
- •15.2 Clinical considerations for CBCT/CT-based online ART
- •15.2.2 Patient and site selection
- •15.2.3 Simulation
- •15.2.4 Pre-planning review
- •15.2.5 Reference planning
- •15.2.9 Limitations and future directions
- •15.3 Summary
- •References
- •16.1 Introduction
- •16.2 Overview of MRI-guided ART systems
- •16.3 MRI-guided ART workflow
- •16.4 AI applications for MRI-guided ART
- •16.4.1 Synthetic CT generation
- •References
- •16.4.2 Auto-segmentation
- •16.4.3 Image registration
- •16.4.4 Others
- •16.4.5 Future AI development and implementation
- •16.5 Summary
- •17.1 Functional PET-guided ART
- •17.1.1 PET-based functional imaging overview
- •17.1.2 From anatomy to function: the power of PET in radiation therapy
- •17.1.5 Conclusions and future prospects
- •17.2 Functional MRI-guided ART
- •17.2.1 From anatomy to function: the power of functional MRI in radiation therapy
- •17.2.4 Conclusion and future prospects
- •17.3 Summary
- •References
- •18.1 Proton ART
- •18.1.1 Clinical context and necessity
- •18.1.2 Patient populations
- •18.1.4 Rationale for AI in proton ART
- •18.2 AI in proton ART
- •18.2.1 Imaging
- •18.2.2 Deformable and rigid registration
- •18.2.3 Contour propagation
- •18.2.4 Dose calculations
- •18.2.5 Plan optimization
- •18.2.6 Other developments
- •18.3 Implementation of adaptive proton therapy
- •18.4 Summary
- •References
- •19.1 Designing clinical trials with AI
- •19.1.1 The essential role of clinical trials
- •19.1.2 Trial protocols and methodologies
- •19.1.3 AI-driven clinical trial design and execution
- •19.1.4 Incorporation of digital twins (DTs) in clinical trials
- •19.2 Implementation of AI in ongoing clinical trials
- •19.2.1 Integration with existing clinical trial frameworks
- •19.2.2 Quality assurance, compliance, and standardization
- •19.3 Case studies of AI in adaptive radiotherapy trials
- •19.3.1 Overview of guidance for advanced radiotherapy in clinical trials
- •19.3.2 AI in the radiotherapy clinical trial quality assurance processes
- •19.4 Ethical and regulatory considerations
- •19.4.1 Patient consent and data privacy
- •19.4.2 Bias, fairness, and transparency
- •19.4.3 Regulatory guidelines and compliance
- •19.5 Future directions and challenges
- •19.5.1 Emerging technologies and techniques
- •19.5.2 Alternative strategies
- •19.6 Conclusion
- •19.7 Summary
- •References
- •20.1 Risk management
- •20.1.1 Prospective risk assessments
- •20.1.2 Root cause analysis

Artificial Intelligence in Adaptive Radiation Therapy
Figure 15.4. Risk priority number (RPN) scoring with and without reference planning review, using failure
mode and effects analysis of the faults from (a) simulation, (b) plan set-up, and (c) plan optimization processes.
The error bars illustrate the mean and standard deviation risk priority number for each failure mode.
(Reproduced with permission from [
63]. Copyright 2024 Elsevier.)
enhance dose shaping), and assign objective weights based on planning priorities.
Some platforms use quality-monitoring functions to guide iterative optimization and
halt refinement once specific clinical goals are satisfied, enabling efficient convergence. These fast optimizers are designed not only to meet planning objectives but
15-12

Artificial Intelligence in Adaptive Radiation Therapy
also to further improve plan quality when time permits. Because these tools influence
both reference and adaptive plan quality, clinical teams must understand their
behavior and limitations when designing planning templates and workflows for
online ART.
The Ethos kV-CBCT online ART platform utilizes a proprietary intelligent
optimization engine (IOE) to automatically generate plans from a planning goal
template submitted to the TPS. The IOE is a hands-off ‘algorithm that orchestrates
the plan optimization’ by seeking to ‘perform all the actions necessary to generate
high-quality dose distributions that meet the clinical expectations for the plan and
ensure that the plan is diametrically accurate’ [103]. This is made possible by
automated creation of helper/optimization structures, deriving non-overlapping
structures in the presence of overlapping structures with opposing objectives, and
assigning objective weights based on the hierarchy of the planning goal template
submitted to the dose preview workspace [104]. The IOE functions by first translating clinical goals into photon optimizer objectives, then generating piecewise
quality functions (Q-functions) for monitoring and influencing the optimization
process. The form of each function prototype (e.g. target upper/lower dose and
organ upper dose) is derived from known features of a good distribution and
generated by assigning a goal priority and relative goal value, allowing each function
to be placed on a priority–quality plane (P, Q)[103]. The optimizer seeks to iterate
until the Q-function meets an individual goal point (P
, Qi), then this goal does not
i
contribute to additional optimizations for lower priority functions. Additionally, the
IOE is designed to further reduce organ and target upper dose levels once all
planning goals are achieved.
For each goal template submitted to th e TPS in the dose preview workspace,
several preselected IMRT (7, 9, or 12 equidistant fields) and VMAT (two and
three full arcs, two partial arcs) plans are automatically optimized and calculated
using a collimator rotation of zero, although custom geometries can be exported
from Eclipse on a patient-by-patient basis. The superior reference plan geometry,
i.e. the plan selected for adaptive treatment, defines the optimization objective
template and geometry utilized for daily online ART plan generation. Many
groups have investigated the quality and clinical acceptability of E thos IOE
automated plans for multiple beam geometries using standardized planning
templates. It has been thoroughly demonstrated that, given a well-designed
template, the IOE automatically generates high-quality standard fractionation
plans for sites in the male and female pelvis [66, 67, 105] and head and neck [106],
with similar and sometimes improved performance compared to manually
generated Eclipse plans [69, 104].
Pogue et al demonstrated that the IOE can automatically produce plans similar in
quality to knowledge-based planning models for locally advanced lung cancer [107].
Furthermore, Visak et al and Roberfroid et al investigated the feasibility of using UNet machine learning models to develop IOE head-and-neck and prostate planning
goals, respectively, on a patient-by-patient basis; they each observed that AI-guided
planning was superior to standard template planning [108, 109]. Additionally,
despite the IOE being designed for organ avoidance planning with homogeneous
15-13

Artificial Intelligence in Adaptive Radiation Therapy
target coverage, multiple groups have effectively developed automated or semi-automated stereotactic planning techniques for APBI [110] and lung and brain
tumors [47, 111]. However, Ethos V2.0 offers a ‘High-Fidelity’ stereotactic planning
selection which largely mitigates the need for many of the complex stereotactic
planning strategies outlined above, with improved online treatment efficiency
observed [112, 113]. It should also be mentioned that several groups observed that
the IOE IMRT plan dosimetry and optimization time was superior to VMAT, likely
due to increased degrees of freedom when gantry angle is included in the
optimization objective function [105, 107]. Given that reference planning defines
online ART optimization, daily VMAT treatments require more time than IMRT
plans, causing some clinics to exclusively adapt using IMRT [105].
Conversely, the uRT-linac 506c TPS, uRT-TPOIS, utilizes a hybrid voxel-based
optimization approach, combining 3D U-Net network dose predictions with a preset
list of clinical objectives [73, 114, 115]. Stochastic gradient descent optimization is
utilized to obtain an optimal solution to the hybrid objective function, which is the
sum of voxel and DVH-based objective functions. This novel, automated treatment
planning system predicts the deliverable dose from a structure set containing target
and OAR contours via U-Net based deep learning, then minimizes the mean
squared error of calculated and predicted dose during optimization, resulting in the
generation of accurate plans during delivery. The Elekta Evo system uses a Monte
Carlo based treatment planning engine within the Elekta ONE TPS to support
adaptive plan generation. Clinical goals—defined through a planning intent—are
translated into optimization objectives that guide the generation of IMRT or
VMAT treatment plans. During re-optimization, users can interactively modify
objective priorities, dose constraints, and normalization values in real time. The
system supports iterative re-planning to improve dose distributions, with automated
handling of overlapping structures and dose shaping objectives.
15.2.6 Patient specific quality assurance
Patient-specific QA (PSQA) for all online ART reference plans is performed using
the same methods as those applied in standard-of-care treatment planning: patientspecific treatment plans are recalculated onto a phantom, then delivered at the
machine and measured, followed by three-dimensional analysis of dose agreement
between the TPS and measured doses. Zhao et al demonstrated that reference plans
agree well with measured doses for 16 patients receiving treatment to various sites
and with differing fractionations [56]. All ion chamber measurements were within
3% absolute dose difference and all cylindrical diode array measurements were
above 95% gamma passing rate (3%/2 mm with 10% threshold). Furthermore, Sibolt
et al performed measurement-based analysis (Delta4+, ScandiDos AB, Uppsala,
Sweden and portal dosimetry) and calculation-based analysis (Mobius3D, Varian
Medical Systems) of 32 bladder and rectum reference plans, finding that both agreed
excellently with Ethos using 3%/2 mm and 3%/3 mm gamma passing criteria,
respectively.
15-14

Artificial Intelligence in Adaptive Radiation Therapy
Specialized software platforms have been developed to enable independent,
calculation-based dose verification for online adaptive radiotherapy, addressing
the limitations of traditional measurement-based QA in time-sensitive adaptive
workflows [116]. These tools should incorporate ultra-fast dose calculation engines
and support comprehensive 3D dosimetric evaluation, including gamma index
analysis and dose–volume histogram comparisons, to ensure the accuracy and
safety of delivered adaptive plans across various treatment systems.
15.2.7 Online ART workflow
The CT-based online ART treatment delivery workflow is dynamic and differs from
the standard-of-care in many ways, several of which can be visualized through a
representative workflow shown in figure 15.5 [61]. In both adaptive and nonadaptive workflows, patients undergo initial CBCT imaging. However, in online
ART, the daily CBCT is further used for organ and target segmentation, which
informs daily plan optimization, if applicable. After careful review by the clinical
team, either the scheduled (non-adaptive) or adaptive plan is selected for treatment.
If the adaptive plan is chosen, a secondary dose calculation is often performed for
quality assurance purposes. Due to the additional time required for contour review
and plan generation in the adaptive workflow, a secondary position verification scan
is recommended prior to treatment delivery.
Figure 15.5. Example CBCT-based online ART and non-adaptive treatment workflows utilized by Stanley
et al. (Reproduced from [
of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American
Association of Physicists in Medicine.)
61] with permission from John Wiley & Sons. Copyright 2023 The Authors. Journal
15-15

Artificial Intelligence in Adaptive Radiation Therapy
15.2.7.1 Patient set-up and daily imaging
After the patient has been set up, the appropriate scanning protocol must be
selected. This step is critical, as the entire online ART workflow may depend on it.
For example, in some systems, the selected algorithm or site determines the
influencer structures, i.e. site-specific organs that guide the deformation of target
and OAR contours from the reference CT to the daily CBCT. There are two
primary reconstruction algorithms offered by Ethos: the analytical and standard
Feldkamp–Davis–Kress (FDK) algorithm [117] and the novel iterative CBCT
(iCBCT) algorithm, which reduces noise and increases contrast via penalized
likelihood statistical analysis [118, 119]. However, iCBCT assumes the patient is
static and is thus highly sensitive to anatomic motion [120]. Therefore, iCBCT
reconstruction should be utilized in the presence of small amounts of motion
(HN, pelvis, b rain, thorax/breast/abdomen utilizing breath-hold) and FDK
reconstruction should be selected given significant anatomic motion (i.e. freebreathe thorax, abdomen, or breast). Conversely, the uRT-linac 506 allows for kV
fan-beam and MV cone-beam CT images to be acquired simultaneously,
simplifying image registration and providing image quality sufficient for direct
dose calculation, as it is nearly free from image degradation due to photon scatter
[48]. Furthermore, the integration of kV and MV imaging enables a significant
reduction of artifacts derived from complex metals compared to traditional
artifact correction methods [121].
15.2.7.2 Contouring
In online ART workflows, some structures may be automatically contoured using
DIR, while others may be segmented using deep learning models such as CNNs
[103]. The method of generation often depends on the anatomical site and available
system capabilities. Because these auto-generated contours may directly influence
downstream processes—such as target propagation, plan optimization, and dose
evaluation—it is essential that the clinical team has a strong understanding of how
each structure is generated and used. Careful review and editing of these contours
are critical to ensure clinical accuracy and safe adaptive plan delivery [103].
15.2.7.3 Plan calculation and selection
In some online ART systems, an sCT is generated by deforming the planning CT to
the daily CBCT using DIR, often relying on mutual information-based cost
functions and spline-based deformation models [122]. Dose calculation for both
scheduled (non-adaptive) and adaptive plans may then be performed on this sCT. In
other systems, dose can be calculated directly on the CBCT itself, provided the
image quality and HU accuracy are sufficient [23]. For systems using sCTs, rigid
alignment between the CBCT and sCT is typically performed prior to dose
calculation, sometimes using target-focused similarity metrics. The same planning
template used for reference planning is applied during daily adaptation, and the
scheduled and adaptive dose distributions are then overlaid on the CBCT anatomy
to support plan selection for treatment.
15-16

Artificial Intelligence in Adaptive Radiation Therapy
15.2.7.4 Quality assurance
Daily online ART plans differ in MU and fluence compared to reference plans, and
should thus be evaluated with PSQA according to traditional professional standards.
However, removing the patient from the treatment couch after daily plan generation
to perform phantom-based measurements can introduce significant set-up uncertainty, which compromises the use of the reduced planning target volume margins
typically employed in online ART. For this reason, PSQA is not typically performed
for online adaptive plans prior to delivery.
Instead of performing phantom-based measurements, adapted plans along with
the corresponding daily CT and structure sets can be exported to an independent
secondary dose calculation system for verifi cation. Prior to adaptive treatment
delivery, it is recommended to compare key dosimetric metrics for target coverage
and OAR sparing between the primary and secondary calculations, and to evaluate
gamma passing rates using clinically appropriate criteria (e.g. 3%/2 mm or 5%/3 mm
with a 95% pass rate). Zhao et al demonstrated that adapted plan dose
calculations on the Ethos system showed good agreement with point dose measurements, patient-specific QA measurements, and independent secondary dose calculations [56]. Furthermore, studies have shown strong correlations between gamma
passing rates from secondary dose calculation systems and measurement-based QA
across both reference and daily adaptive plans, suggesting that independent dose
calculations may serve as an effective QA approach for CBCT-based online ART,
particularly when the reference plan has passed initial validation [55].
After secondary dose calculation and evaluation, many clinics will perform a
position verification CBCT to account for patient movement and/or anatomy
change since the initial CBCT [61, 119], although this may not be required by the
delivery system. Once shifts are applied, the patient is ready for treatment. For
patients without significant respiratory motion, surface-guided radiotherapy
(SGRT) systems can be used to monitor intrafraction motion by tracking the
displacement of the surface centroid in real time [123]. In cases requiring breath-hold
motion management, the vertical displacement component is often used to monitor
chest wall motion and ensure consistency with the planned breath-hold position. In
high-precision workflows such as breath-hold CBCT-guided stereotactic adaptive
radiotherapy (CT-STAR), deviations beyond a predefined threshold (e.g. 2 mm
vertically) can trigger the acquisition of an intrafraction CBCT to verify
target alignment [124]. Alternative motion management strategies may include
visually guided respiratory training, where patients adjust their breathing to match a
predefined amplitude window, supported by either commercial or in-house software
solutions. Furthermore, online electronic portal imaging device (EPID) analysis
could be used for motion monitoring. Peng et al used the EPID panel for monitoring
in vivo doses from adaptive radiation therapy for cervical cancer. If the global
gamma passing rate fell below 88% using a 3%/3 mm threshold, treatments were
suspended or terminated pending further investigation [68]. They observed that all
plans were at or above a 89% pass rate for six patients, supporting accurate uRTlinac 506c adaptive cervical cancer treatment delivery. The feasibility of this
methodology has also been demonstrated for rectal cancer patients [125]. Due to
15-17

Artificial Intelligence in Adaptive Radiation Therapy
the inability to detect online ART plan deliverability issues without PSQA, Sun et al
developed a machine learning-based ensemble model for predicting gamma passing
rate for uRT-linac 506c SBRT plans. They observed areas under the receiver
operator characteristic curve of 0.87 and 0.84 for the 2%/2 mm and 1%/2 mm
criteria, respectively, using the ensemble of plan and radiomic models [126].
15.2.8 Offline contour and plan evaluation
Offline contour and plan evaluation in the context of CT-based adaptive radiotherapy extends beyond the initial adaptation process to encompass a comprehensive verification step post-delivery. This phase involves assessing the created plans
and contours to ensure concordance with reference plan contour definitions and
efficacy in responding to anatomical or physiological changes observed during
treatment. Additionally, offline review can be utilized as an opportunity to identify
potential changes to the planning directive that can result in an improved plan.
Following the delivery of adaptive radiotherapy, the verification process is crucial
for confirming the validity of the offline adaptation approach. This involves a
detailed analysis of the treated anatomy through comparison with the original
treatment plan and the overall objectives of the physician directive. An essential
aspect of this verification is the examination of the acquired and created images,
where the contours from the planning CT are either propagated or redrawn to the
daily anatomy, and the planned dose is recalculated on the current daily anatomy.
The goal is to confirm that the adapted plan aligns with the intended treatment goals
and adequately addresses any anatomical deviations that may have occurred during
the course of treatment. This requires a high level of understanding and communication amongst the treatment team of the goals for the particular patient.
Additionally, with systems that utilize sCT, a pivotal role of the offline assessment
is in ensuring the precision and reliability of the generated sCT, particularly in areas
of high heterogeneity [99]. The sCT should align closely with the actual patient
anatomy, and contours derived from the sCT should accurately represent the target
volumes and OARs, as discrepancies in contouring may lead to deviations in dose
calculation and subsequent treatment outcomes. While it is not possible to change
the sCT with current software versions, evaluation of large discrepancies in sCT can
necessitate the need for a re-simulation or changes to the structures and contours.
Lastly, offline dose accumulation review can be used to inform the reviewer of the
effects of anatomical variations on the summed, delivered dose. For Ethos, the
deformation vector field used in the structure guided DIR is utilized to propagate
dose from the sCT to the planning CT. Because of the high-impact that dose
mapping and accumulation has on online ART, the results should be closely
monitored and methods should be continuously improved [38]. An example of the
effects daily adaption may have on dose accumulation, hot and cold spots vary in
position daily with adaption, but occur in the same position every day during nonadaptive treatment, leading to greater target homogeneity with online ART [83].
Furthermore, Peng et al found good agreement between TPS accumulated adaptive
cervical cancer RT dose and three-dimensional dose reconstruction derived from
15-18

Artificial Intelligence in Adaptive Radiation Therapy
two-dimensional EPID measurements for the uRT-linac 506c [68]. This novel
quality assurance step has even been utilized to verify excellent agreement between
planned and delivered dose for total bone marrow lymphoid IMRT in the nonadaptive setting [127].
15.2.9 Limitations and future directions
Despite the advancements in offline adaptive strategies, there are inherent limitations and areas for future development. Further integration of clear, site-specific
thresholds for determining which patients are the optimal candidates for online
ART is needed, and understanding the criteria that warrant adaptive planning is
essential for optimizing treatment outcomes. Active offline monitoring and utilization of innovative technologies and artificial intelligence holds promise for allowing
detection of subtle anatomical changes that may necessitate adaptation.
Additionally, the exploration of adaptive dose calculation time reduction
techniques, particularly with high-quality CBCTs versus sCT, represents a potential
avenue for future research. Integrating AI into the dose calculation and evaluation
processes may further refine the accuracy of adaptive strategies. Research efforts
should focus on developing robust models that can predict dosimetric changes based
on patient-specific characteristics and treatment parameters.
15.3 Summary
Offline CT-based ART and online CBCT-based ART represent two complementary
strategies for adapting radiotherapy plans in response to patient-specific anatomical
changes. Offline ART is typically triggered by anatomical changes observed on
routine imaging and involves re-simulation, re-contouring, and re-planning with
plan summation to assess cumulative dose. While beneficial, offline ART can be
resource-intensive and susceptible to registration uncertainties, requiring robust QA
and careful patient selection.
Online ART leverages on-board imaging systems and intelligent optimization
platforms to adapt treatment plans in real time, offering precision in daily plan
delivery. Clinical adoption remains limited due to challenges in sCT accuracy,
resource demands, and workflow complexity. Nevertheless, ongoing advances in AIbased automation, predictive modeling, and integrated QA frameworks are improving feasibility and clinical value.
Together, these approaches highlight the evolving landscape of adaptive radiotherapy, emphasizing the importance of streamlined workflows, reliable image
registration, intelligent planning tools, and thoughtful implementation strategies
to optimize treatment outcomes.
References
[1] Green O L, Henke L E and Hugo G D 2019 Practical clinical workflows for online and
offline adaptive radiation therapy Semin. Radiat. Oncol.
[2] Schwartz D L et al 2013 Adaptive radiotherapy for head and neck cancer—dosimetric
results from a prospective clinical trial Radiother. Oncol.
29 219–27
106 80–4
15-19

Artificial Intelligence in Adaptive Radiation Therapy
[3] Kong F-M et al 2017 Effect of midtreatment PET/CT-adapted radiation therapy with
concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: a
phase 2 clinical trial JAMA Oncol
[4] Cai B, Green O L, Kashani R, Rodriguez V L, Mutic S and Yang D 2018 A practical
implementation of physics quality assurance for photon adaptive radiotherapy Z. Für. Med.
Phys.
28 211–23
[5] Krishnatry R, Bhatia J, Murthy V and Agarwal J P 2018 Survey on adaptive radiotherapy
practice Clin. Oncol.
[6] Bertholet J et al 2020 Patterns of practice for adaptive and real-time radiation therapy
(POP-ART RT) part II: offline and online plan adaption for interfractional changes
Radiother. Oncol.
[7] Brown E et al 2015 Predicting the need for adaptive radiotherapy in head and neck cancer
Radiother. Oncol.
[8] Brouwer C L, Steenbakkers R J H M, Langendijk J A and Sijtsema N M 2015 Identifying
patients who may benefit from adaptive radiotherapy: does the literature on anatomic and
dosimetric changes in head and neck organs at risk during radiotherapy provide information to help? Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol.
[9] Heukelom J and Fuller C D 2019 Head and neck cancer adaptive radiation therapy (ART):
conceptual considerations for the informed clinician Semin. Radiat. Oncol.
[10] Maniscalco A, Liang X, Lin M-H, Jiang S and Nguyen D 2023 Single patient learning for
adaptive radiotherapy dose prediction Med. Phys.
[11] Lee D et al 2022 Deep learning driven predictive treatment planning for adaptive
radiotherapy of lung cancer Radiother. Oncol.
[12] Wang C et al 2019 Toward predicting the evolution of lung tumors during radiotherapy
observed on a longitudinal MR imaging study via a deep learning algorithm Med. Phys.
4699–707
[13] Barragán-Montero A M, Van Ooteghem G, Dumont D, Rivas S T, Sterpin E and Geets X
2023 Dosimetrically triggered adaptive radiotherapy for head and neck cancer: considerations for the implementation of clinical protocols J. Appl. Clin. Med. Phys.
[14] Liang X et al 2021 Automated contour propagation of the prostate from pCT to CBCT
images via deep unsupervised learning Med. Phys.
[15] Liu Y et al 2020 CBCT-based synthetic CT generation using deep-attention cycleGAN for
pancreatic adaptive radiotherapy Med. Phys.
[16] Liang X et al 2019 Generating synthesized computed tomography (CT) from cone-beam
computed tomography (CBCT) using CycleGAN for adaptive radiation therapy Phys.
Med. Biol.
[17] Chen L, Liang X, Shen C, Jiang S and Wang J 2020 Synthetic CT generation from CBCT
images via deep learning Med. Phys.
[18] Maspero M et al 2020 A single neural network for cone-beam computed tomography-
based radiotherapy of head-and-neck, lung and breast cancer Phys. Imaging Radiat.
Oncol.
[19] Kisling K D et al 2018 A snapshot of medical physics practice patterns J. Appl. Clin. Med.
Phys.
[20] Yuan Z, Rong Y, Benedict S H, Daly M E, Qiu J and Yamamoto T 2020 Dose of the day’
based on cone beam computed tomography and deformable image registration for lung
cancer radiotherapy J. Appl. Clin. Med. Phys.
64 125002
14 24–31
19 306–15
30 819
153 88–96
116 57–63
3 1358–65
115 285–94
29 258–73
50 7324–37
169 57–63
46
24 e14095
48 1764–70
47 2472–83
47 1115–25
21 88–94
15-20

Artificial Intelligence in Adaptive Radiation Therapy
[21] Moteabbed M, Sharp G C, Wang Y, Trofimov A, Efstathiou J A and Lu H-M 2015
Validation of a deformable image registration technique for cone beam CT-based dose
verification Med. Phys.
[22] Veiga C et al 2014 Toward adaptive radiotherapy for head and neck patients: feasibility
study on using CT-to-CBCT deformable registration for ‘dose of the day’ calculations Med.
Phys.
41 031703
[23] Duan J et al 2025 Assessing HyperSight iterative CBCT for dose calculation in online
adaptive radiotherapy for pelvis and breast patients compared to synthetic CT J. Appl. Clin.
Med. Phys.
[24] Bojechko C, Hua P, Sumner W, Guram K, Atwood T and Sharabi A 2022 Adaptive
replanning using cone beam CT for deformation of original CT simulation J. Med. Radiat.
Sci.
[25] Schiff J P et al 2023 Prospective in silico evaluation of cone-beam computed tomography-
guided stereotactic adaptive radiation therapy (CT-STAR) for the ablative treatment of
ultracentral thoracic disease Adv. Radiat. Oncol.
[26] Mencarelli A et al 2014 Deformable image registration for adaptive radiation therapy
of head and neck cancer: accuracy and precision in the presence of tumor changes
Int. J. Radiat. Oncol. Biol. Phys.
[27] Berenguer R et al 2018 The influence of the image registration method on the adaptive
radiotherapy. A proof of the principle in a selected case of prostate IMRT Phys. Med.
93–8
[28] Rigaud B et al 2021 Automatic segmentation using deep learning to enable online dose
optimization during adaptive radiation therapy of cervical cancer Int. J. Radiat. Oncol.
1096–110
[29] Cardenas C E, Yang J, Anderson B M, Court L E and Brock K B 2019 Advances in
auto-segmentation Semin. Radiat. Oncol.
[30] Lowther N J, Marsh S H and Louwe R J W 2020 Quantifying the dose accumulation
uncertainty after deformable image registration in head-and-neck radiotherapy Radiother.
Oncol.
[31] Brock K K, Mutic S, McNutt T R, Li H and Kessler M L 2017 Use of image registration
and fusion algorithms and techniques in radiotherapy: report of the AAPM radiation
therapy committee task group no. 132 Med. Phys.
[32] Fu Y, Lei Y, Wang T, Curran W J, Liu T and Yang X 2020 Deep learning in medical image
registration: a review Phys. Med. Biol.
[33] Ghesu F-C et al 2019 Multi-scale deep reinforcement learning for realttime 3D-landmark
detection in CT scans IEEE Trans. Pattern. Anal. Mach. Intell.
[34] Fu Y et al 2020 LungRegNet: an unsupervised deformable image registration method for
4D-CT lung Med. Phys.
[35] Kearney V, Haaf S, Sudhyadhom A, Valdes G and Solberg T D 2018 An unsupervised
convolutional neural network-based algorithm for deformable image registration Phys.
Med. Biol.
[36] Maintz J B A and Viergever M A 1998 A survey of medical image registration Med. Image
Anal.
[37] Guan H and Dong H 2009 Dose calculation accuracy using cone-beam CT (CBCT) for
pelvic adaptive radiotherapy Phys. Med. Biol.
26 e70038
69 267–72
143 117–25
63 185017
2 1–36
42 196–205
8 101226
90 680–7
45
109
29 185–97
44 e43–76
65 20TR01
41 176–89
47 1763–74
54 6239
15-21
Соседние файлы в папке Библиотека им академика М.И. Перельмана
